Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CYTKCYTK
Showing 8 of 30 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in CYTOKINETICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 1.4M shares of CYTK (CYTOKINETICS INC), worth $92.1M as of 2026-Q1. The position was increased (+1.0% shares). CYTK represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$92.1M

Current Shares

1.4M

Total Value Change

+$41.9M

Total Shares Change

+471,363

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.4M
+1.0%
$92.1M0.0%$60.72
30
2025-Q4
Increased
1.4M
+0.7%
$87.9M0.0%$61.37
30
2025-Q3
Increased
1.4M
+1.2%
$75.5M0.0%$53.89
30
2025-Q2
Increased
1.4M
+3.4%
$44.8M0.0%$33.16
30
2025-Q1
Decreased
1.3M
-1.7%
$52.8M0.0%$43.19
0
2024-Q4
Increased
1.3M
+1.0%
$62.8M0.0%$47.15
30
2024-Q3
Increased
1.3M
+42.8%
$69.8M0.0%$52.34
40
2024-Q2
Increased
925,682
+19.4%
$50.2M0.0%$54.18
35

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used